Outcomes After Liver and Biliary Resection at a High-Volume Center
Starting soon
Conditions studied: Liver Neoplasms, Hepatobiliary Diseases, Cholangiocarcinoma, Hepatocellular Carcinoma, Liver Metastases From Colorectal Cancer, Liver Metastases, Biliary Tract Diseases, Benign Liver Disease, Gallbladder Carcinoma
In brief
The goal of this observational study is to evaluate clinical and oncologic outcomes in adult patients undergoing liver and/or biliary resection for benign and malignant diseases. This study evaluates postoperative morbidity and mortality within 90 days after surgery, as well as overall survival and disease-free survival in patients with malignant disease. Participants will: * undergo standard surgical and perioperative management according to routine clinical practice * have clinical, surgical, and follow-up data collected from institutional medical records * be followed for postoperative outcomes and long-term oncologic outcomes up to 5 years
Key facts
- Study ID
- NCT07556835
- Run by
- Azienda USL Toscana Centro
- People needed
- 1000
- Starts
- 2026-04-01
- Expected to finish
- 2036-12-01
- Last updated by the study team
- 2026-04-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥ 18 years
- Patients undergoing liver resection and/or biliary resection at San Jacopo Hospital, Pistoia
- Diagnosis of benign or malignant hepatobiliary disease
- Availability of clinical, surgical, and follow-up data
- For the prospective cohort, provision of written informed consent when required according to local regulations
You may not qualify if…
- Age < 18 years
- Pregnancy
- No liver or biliary resection performed
- Biopsy only without resection
- Refusal or unavailability of consent for the prospective cohort when consent is required
Where it is running
- San Jacopo Hospital — Pistoia, Tuscany, Italy
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.